In contrast, the PKC activator bryostatin-1 (Figure 1), a monocyclic lactone originally derived from a marine bryozoan and now available by synthesis, shows unique anticancer activities with little tumor promotion [75]. The gene discussed is PRRT2; the disease is neoplasm.